Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study


Hernandez, Cristina, Simo-Servat, Olga, Porta, Massimo, Grauslund, Jakob P, Harding, Simon ORCID: 0000-0003-4676-1158, Frydkjaer-Olsen, Ulrik, Garcia-Arumi, Jose, Ribeiro, Luisa, Scanlon, Peter, Cunha-Vaz, Jose et al (show 1 more authors) (2023) Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study. ACTA DIABETOLOGICA, 60 (6). pp. 837-844.

[img] Text
ActaDiabetol_Biomarkers_22_12_22.docx - Author Accepted Manuscript
Download (144kB)

Abstract

<h4>Aims</h4>Neurodegeneration and glial activation are primary events in the pathogenesis of diabetic retinopathy. Serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) are biomarkers of underlying neuroinflammatory and neurodegenerative disease processes. The aim of the present study was to assess the usefulness of these serum biomarkers for the identification and monitoring of retinal neurodysfunction in subjects with type 2 diabetes.<h4>Methods</h4>A case-control study was designed including 38 patients from the placebo arm of the EUROCONDOR clinical trial: 19 with and 19 without retinal neurodysfunction assessed by multifocal electroretinography. GFAP and NfL were measured by Simoa.<h4>Results</h4>Serum levels of GFAP and NfL directly correlated with age (r = 0.37, p = 0.023 and r = 0.54, p < 0.001, respectively). In addition, a direct correlation between GFAP and NfL was observed (r = 0.495, p = 0.002). Serum levels of GFAP were significantly higher at baseline in those subjects in whom neurodysfunction progressed after the 2 years of follow-up (139.1 ± 52.5 pg/mL vs. 100.2 ± 54.6 pg/mL; p = 0.04).<h4>Conclusions</h4>GFAP could be a useful serum biomarker for retinal neurodysfunction. Monitoring retinal neurodysfunction using blood samples would be of benefit in clinical decision-making. However, further research is needed to validate this result as well as to establish the best cutoff values.

Item Type: Article
Uncontrolled Keywords: Diabetic retinopathy, Glial fibrillary acidic protein, Neurofilament light chain, Retinal neurodysfunction, Serum biomarkers
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 06 Jul 2023 13:54
Last Modified: 23 Mar 2024 02:30
DOI: 10.1007/s00592-023-02076-1
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3171228
Dimensions
Altmetric
CORE (COnnecting REpositories)